4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-050224
Chief Financial Officer sold 10,000 shares at $40.00 ($400,000)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-10 | Exercise or conversion : show line 1 in the form | +1,412 | $6.32 | $8,924 | 2,412 | D |
| 2020-09-10 | Sale : show line 2 in the form | −1,412 | $40.00 | $56,480 | 1,000 | D |
| 2020-09-11 | Exercise or conversion : show line 3 in the form | +8,588 | $6.32 | $54,276 | 9,588 | D |
| 2020-09-11 | Sale : show line 4 in the form | −8,588 | $40.00 | $343,520 | 1,000 | D |
| Open-market sales · 10,000 sh · avg $40.00 · $400,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-10 | Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) | −1,412 | 588,588 | D |
| 2020-09-11 | Exercise or conversion : show line 6 in the form Stock Option (Right To Buy) | −8,588 | 580,000 | D |
Loading xslF345X03/doc4.xml…